Congreso ACC.21 (Congreso do American College of Cardiology 2021) (Vídeos)
CONSEGUIRÁ O CURSO EN LIGA DE DESCARGA POR VIDA (VELOCIDADE RÁPIDA) DESPOIS DO PAGO
*Congreso do Colexio Americano de Cardioloxía 2021*
ACC.21, o All Virtual Experience, contará coa investigación clínica e a educación de última xeración en 11 vías de aprendizaxe nun foro atractivo e interactivo que ofrece as últimas actualizacións de coidados que cambian a práctica.
Participa en máis de 200 sesións en 11 itinerarios de aprendizaxe que inclúen ciencias de última xeración, investigacións que cambian as prácticas e educación de vangarda que esperas da sesión científica anual da Facultade.
Explora a Expo e obtén máis información sobre os últimos avances en produtos farmacéuticos, imaxes, dispositivos, informática sanitaria e os servizos que necesitas para ofrecer unha atención de alta calidade aos teus pacientes. Chatea cos expositores participantes para obter respostas ás túas preguntas.
Únete a nós para o 70th Convocatoria anual mentres recoñecemos aos gañadores dos premios 2021 e as súas contribucións ao ACC e á profesión, dámoslle a benvida a novos compañeiros e asociados e recoñecemos ao novo presidente da ACC, Dipti Itchhaporia, MD, FACC.
Do 15 ao 17 de maio ACC.21 transmitido a miles de membros do equipo cardiovascular de todo o mundo! Tómate o tempo para explorar TODA a educación de ACC.21 con acceso baixo demanda. Mira máis de 300 sesións sobre investigacións que cambian a práctica e educación de vangarda. Ademais, non perdas os máis de 3,3000 resumos electrónicos, máis de 100 expositores e a oportunidade de celebrar os logros dos nosos compañeiros con Convocation. Mostra dunha variedade de educación inigualable cando che resulte conveniente (desde a túa casa, oficina ou estea en movemento) a través de 11 vías de aprendizaxe. A ACC.21 deixarache actualizado sobre as investigacións clínicas máis recentes e descubrirás como todo isto repercute na atención dos teus pacientes.
ACC é a conferencia anual do American Automatic Control Council (AACC), a organización membro nacional estadounidense da Federación Internacional de Control Automático (IFAC). Os copatrocinadores da sociedade nacionais e internacionais de ACC inclúen o Instituto Americano de Aeronáutica e Astronáutica (AIAA), o Instituto Americano de Enxeñeiros Químicos (AIChE), a Sociedade Americana de Enxeñeiros Civís (ASCE), a Sociedade Americana de Enxeñeiros Mecánicos (ASME), o IEEE Control. Systems Society (IEEE-CSS), Institute for Operations Research and the Management Sciences (INFORMS), International Society of Automation (ISA), Society for Modeling & Simulation International (SCS) e Society for Industrial & Applied Mathematics (SIAM).
*Contido: (297 vídeos)
| 406 Joint American College of Cardiology Journal of the American Medical Association Late-Breaking Clinical Trials.ts
| 407 Joint American College of CardiologyNew England Journal of Medicine Late-Breaking Clinical Trials.ts
| 411 Late-Breaking Clinical Trials V.ts
| 908 Highlighted Original Research Multimodality Imaging and the Year in Review.ts
| 910 Highlighted Original Research Ischemic Heart Disease and the Year in Review.ts
| A Contemporary Understanding of the Diagnosis and Management of Low Flow Low Gradient Severe Aortic Stenosis.ts
| A Melting Pot of Clinical Valvular Heart Disease Cases No Cookbook, but a Practical Applications from the Valve Guidelines.ts
| A Practical Approach to Shared Decision Making when Treating Heart Valve Disease.ts
| A Review of the RADIANCE-HTN Global Clinical Trial Program A Focus on the TRIO cohort.ts
| ACC Cardiology Hour.ts
| ACC.21 Highlights in Hypertension.ts
| ACC21-Frequently-Asked-Questions-UPLOADED-May-11-2021.pdf
| Acing the Transition What FITs Need to Know to Launch a Healthy, Successful Career.ts
| Adult Congenital Heart Disease Cases That Stumped Me.ts
| Advanced Nuclear Cardiology Applications in 2021.ts
| Advances and new studies for the treatment of MR with Abbott’s TMV repair and replacement therapies.ts
| Advancing Patient Care Across the Heart Failure Continuum.ts
| Advancing Systems of Care in STEMI, Stroke, Cardiac Arrest, Shock.ts
| Anticoagulation Trivia from A to V Management Strategies Across the Board Meeting on Demand.mp4
| Antithrombotic Controversies in the Cath Lab.ts
| Antithrombotic Management in Patients with Atrial Fibrillation Undergoing PCI.ts
| Aortic Valve Interventions Clinical Dilemmas.ts
| Aortic Valve Interventions Expanding Indications.ts
| Application of Dual Source CT in cardiac imaging – a focus on Structural Heart Disease.ts
| Applying the Guidelines For Lipid Management in Special Populations.ts
| Arrhythmogenic Cardiomyopathies Tell Me What I Need to Know.ts
| ASCVD Risk Factors and Beyond.ts
| Atrial Fibrillation Management in Athletes.ts
| Best of JACC Journals & Eugene Braunwald Keynote.ts
| Best Practices of Multimodality Imaging in Percutaneous Mitral Interventions.ts
| Beyond a Broken Heart Multisystem Disease Burden in hATTR Amyloidosis.ts
| Beyond Atrial Fibrillation – Atrial Cardiopathy as a Cause of Cryptogenic Stroke.ts
| Bleeding Reduction Strategies Following PCI.ts
| Breakthrough Transcatheter Pulmonary Valve Treatment Option for Adult and Pediatric CHD Patients.ts
| Cardiac CT in Clinical Practice.ts
| Cardiac Culture Medium Current Concepts in Infective Endocarditis.ts
| Cardiac Imaging in Older Adults Overused or Underutilized Practical Points for Clinicians.ts
| Cardiac Point of Care Ultrasound Around the World.ts
| Cardiac Rehab Move to Improve.ts
| Cardio-Oncology Today’s Standard of Practice.ts
| Cardiogenic Shock Progress, Paradigms and Unresolved Problems.ts
| Cardiogenic Shock Teams and Devices for Cardiogenic Shock.ts
| Cardiologist Versus Calcium Unstoppable Force Meets Immovable Object.ts
| Cardiovascular Considerations in Amateur and Professional Athletes.ts
| Cardiovascular Imaging For Diagnosis And Management of Coronary Microvascular Disease.ts
| Cardiovascular Imaging to Enhance Prevention.ts
| Caring for the Patient with STEMI in 2021.ts
| Case Based Learning for the Cardiovascular Team.ts
| Cases from the Guidelines for Clinicians.ts
| CCM® Therapy – A Device Based Approach for the Treatment of Heart Failure.ts
| Challenges of Transplantation in Congenital Heart Disease Patients Ethics, Listing Strategy & MCS.ts
| Challenging Cases in Cardio-Oncology.ts
| Chest Pain Evaluation in 2021 Same Problem, New Tools, New Questions.ts
| Clarity From Confusion in Heart Failure With Preserved Ejection Fraction (HFpEF).ts
| Clinical Trials Research Upping Your Game.ts
| Clinical Trials ThunderDome Who Will Be Crowned Most Impactful.ts
| Complex and High-Risk PCI Case Based Joint Symposium.ts
| Complex Case-Based Decision-Making – The Heart Team in Action A Joint Symposium by TCT.ts
| Complex Dilemmas in Valvular Heart Disease.ts
| Contemporary Aortic Valve Disease Management.ts
| Contemporary Challenges in Cardiac Critical Care Structure, Staffing, Training and Beyond.ts
| Controversial Topics in Cardiac Transplantation and Ventricular Assist Devices.ts
| Controversies in Arrhythmia Therapy.ts
| Controversies in Interventional and Surgical Management of Congenital Heart Disease.ts
| Controversies in the ICU Management of Congenital Heart Disease.ts
| Core Knowledge in Action Essentials of Stable Ischemic Heart Disease.ts
| Core Knowledge in Action Return to the Basics of Aortic Stenosis.ts
| Core Knowledge in Action The Ultimate Guide to Lipids.ts
| Core Knowledge in Action What Everyone Ought To Know About HFpEF.ts
| Coronary Artery Disease – Atherogenesis, Acute Coronary Syndromes and Stroke.ts
| Coronary IVL’s Who, What, Where, When & Why An Introductory Guide for Clinical Practice.ts
| COVID 19 and Heart Failure Lessons Learned and Future Directions.ts
| COVID-19 and Echocardiography – Impact, Imaging, and Innovation.ts
| Critical Clinical Conundrums in Acute Coronary Syndromes.ts
| Current Approaches to Antiplatelet Therapy for PCI in Acute Coronary Syndrome.ts
| Current Controversies And Debates in CAD Imaging.ts
| CVD Prevention in the Post-COVID19 Era2.ts
| Debates in Arrhythmia Management in Congenital Heart Disease.ts
| Debates Should We Tailor Antiplatelet Therapy for PCI.ts
| Debating Controversies in STEMI Care.ts
| Deep Dive I.ts
| Deep Dive II.ts
| Destined to Fail How to Prevent Heart Failure.ts
| Diabesity A Tale of Obesity, Inflammation and Cardiometabolic Risk.ts
| Diabetes and Heart Failure.ts
| Diagnostic Testing in Stable Ischemic Heart Disease Choosing Wisely.ts
| Disparities and the Role of Social Determinants of Health in Acute and Stable Ischemic Heart Disease.ts
| Dissecting the Data Discussions on the Management of SCAD.ts
| Doorways To The Heart Valves In Systemic Disease.ts
| Drug Jeopardy Pharmacological Conundrums in Arrhythmia Management.ts
| ECGs With the Experts Practical Considerations For the Cardiovascular Clinician.ts
| Electrical Disorders – Rhythm and Conduction Disorders.ts
| Emerging Technologies in Vascular Disease.ts
| Endovascular Skills Basics to Bailout Techniques.ts
| EP Issues in Cancer Patients – Beyond Heart Failure.ts
| Essential Vascular Pearls for the Cardiovascular Clinician.ts
| Essentials of Atrial Fibrillation Management – Learn From the Experts.ts
| Evolution of Aortic Valve Replacement in Low-Risk Patients.ts
| Expanding Frontiers in Vascular Intervention.ts
| Expanding the Toolkit Tackling Residual Atherogenic Lipid Risk.ts
| Exploring New Synergies Integrating a Cardiac CT Scanner and Interventional C-arm in our Cath Lab.ts
| Featured Clinical Research I.ts
| Featured Clinical Research II.ts
| Featured Clinical Research III.ts
| Fellows Bootcamp Coronary and Peripheral Disease Management – The Best Cases You Have Seen Yet.ts
| Fellows Bootcamp Structural.ts
| FIT Forum Stump the Professor.ts
| FIT Jeopardy Battle of the State Chapters Finals.ts
| Focus on Interventional Complications.ts
| Four Models of Myocardial Disease & Heart Failure – Myocarditis, HFrEF, HFpEF, HCM.ts
| From Controversy to Clarity in Weight Loss Therapies.ts
| Fusion imaging for transcatheter edge-to-edge mitral valve repair.ts
| Gender-Specific Care of Patients with Acute Coronary Syndrome.ts
| Genetics through Geriatrics – CV Prevention Through the Lifespan.ts
| Getting to the Root of Dietary Effects.ts
| Getting Your Life-and-Style Back in CVD.ts
| Global Burden of Cardiovascular Disease in Women.ts
| Global Leadership and Professional Education in the COVID-19 Era.ts
| Great Debates in Vascular Medicine.ts
| Harnessing the Power of Technology Remote Monitoring and Management in HF.ts
| Help LDL.ts
| Help Your Recent MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI (2).ts
| Help Your Recent MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI.ts
| Hemodynamics of Heart Failure You Thought You Knew Them.ts
| Heterotaxy Syndrome or Somerism Whose Side Are You On.ts
| Highlighted Original Research Electrophysiology and the Year in Review.ts
| Highlighted Original Research Heart Failure and Cardiomyopathies and the Year in Review.ts
| Highlighted Original Research Interventional and Structural and the Year in Review.ts
| Highlighted Original Research Pediatric and Congenital Heart Disease and the Year in Review.ts
| Highlighted Original Research Prevention and Health Promotion and the Year in Review.ts
| Highlighted Original Research Pulmonary Vascular Disease and the Year in Review.ts
| Highlighted Original Research Valvular Heart Disease and the Year in Review.ts
| Highlighted Original Research Vascular Medicine and the Year in Review.ts
| Holy Estrogen! Sex Disparities in Heart Failure Therapies Biology, Bias or Both.ts
| How Can I Tell If This Aortic Valve Replacement Is Functioning Normally.ts
| How does Paradise Renal Denervation Fit Into Hypertension Treatment Management.ts
| How Much is Too Much Navigating Medication Overload by Medication Deprescribing.ts
| How to be an Effective Mentor & Mentee.ts
| How to Become a Successful Researcher at Every Stage of Your Career.ts
| How to Choose and Optimize Pacing in Patients with Heart Failure Conduction System Pacing and CRT.ts
| How to Deal With Cases That Go From No Problem to Nightmare.ts
| How to Stent a LM Like a Boss Left Main PCI Workshop.ts
| Hypertension Guidelines Do They Vary Across the World as Much as My Blood Pressure Has Today .ts
| Hypertension Management A Future Full of Promises.ts
| I Know the Evidence So How Do I Incorporate Nutrition and Lifestyle in My Clinic.ts
| Imagination is Everything Innovations in the Cath Lab.ts
| Imaging Cardiomyopathies Challenging Cases.ts
| Imaging Decision Making in Everyday Clinical Practice for Coronary Artery Disease.ts
| Imaging of Congenital Heart Disease Seeing Things We Never Saw Before.ts
| Implementing Rhythm Control Guidelines in Atrial Fibrillation The Good, The Bad, and The Ugly.ts
| Indirect Valvular Heart Disease Problems and Perspectives.ts
| Innovative Nutritional and Dietary Approaches for Cardiometabolic Disease.ts
| Insight of BAV Disease from Asia and Western Perspectives.ts
| International Centers of Excellence Todays Solutions for an Improved Tomorrow.ts
| Interventional Challenging Cases II An Interventional & SHD Potpourri Not to Miss.ts
| Interventional Challenging Cases Will Make You Think.ts
| Invasive Imaging and Physiology Diagnosis and Management of ACS Patients and Plaques.ts
| Is the Quality of Cardiovascular Research Declining What Research Should Continue to be Pursued.ts
| Jardiance® (empagliflozin) tablets The Impact of EMPA-REG OUTCOME.ts
| Jeopardy.ts
| Journey of the Right Ventricle in Pulmonary Hypertension.ts
| Kick Starting Your Research Career.ts
| Late-Breaking Clinical Trials IV.ts
| Late-Breaking Clinical Trials.ts
| Launching a Successful Career in Academic Cardiology Key Points to Success.ts
| Left Atrial Appendage Occlusion Clinical Challenges.ts
| Left Ventricular Ejection Fraction Past, Present, and Future Role in Heart Failure Care.ts
| Let’s Get Physical! Exercise and Cardiovascular Health.ts
| Lifelong Impact of Cardiovascular Risk Factors in Patients with Congenital Heart Disease.ts
| Living in 3D.ts
| Lower Extremity PAD Diagnostic Dilemmas, Disparities, and Patient Centered Outcomes.ts
| Management of Pediatric Cardiology and Cardiac Surgery in the Post-COVID World.ts
| Managing the Device Patient in 2021 From Cybersecurity, to MRI and Beyond.ts
| Managing Today’s Advanced Heart Failure Patient.ts
| Men Are From Mars, Women Are From Venus Sex-Specific Risk Factors That Enhance CVD Risk.ts
| Minimally Invasive Therapies and Devices in AHF Featuring the 2021.ts
| MINOCA A Show and Tell With the Experts.ts
| Mitral Valve Disease and Cardiac Arrest Innocent Bystander or Guilty As Charged.ts
| Mitral Valve Interventions Percutaneous Mitral Valve Repair.ts
| Mobile ECG Monitoring How Can We Utilize Wearable Data.ts
| Multimodality Cardiac Imaging and Modern Media.ts
| Multimodality Imaging in Cardio-Oncology.ts
| Multimodality Imaging in Challenging Cases of Infective Endocarditis.ts
| Multimodality Imaging of Athletes What Do The New Consensus Statement Teach Us.ts
| Must Know Tips for Publishing in JACC Journals.ts
| Myocarditis and Heart Failure.ts
| New AHAACC Valve Guidelines A Paradigm Shift in Management of Severe Aortic Stenosis.ts
| New and Emerging Breakthrough Medicines for HFrEF! Now What Do We Do.ts
| New Hypertension Therapies in Asian People.ts
| New Innovations in Cardiovascular Imaging Incorporating Artificial Intelligence Into Daily Practice.ts
| New Recommendations on How to Monitor Patients Post TAVRSAVR.ts
| Nuts & Bolts of Pregnancy and Congenital Heart Disease.ts
| Obstructive Sleep Apnea and Cardiovascular Outcomes What do Cardiologists Need to Know.ts
| Off-Beat Topics in Heart Failure Improving Dysfunction By Treating the Rhythm.ts
| Optimizing LDL-C Management in Recent MI Patients A Focus on Multidisciplinary Care Team Approach.ts
| Optimizing the Patient Care Pathway and LDL-C Management in Patients with Recent MI.ts
| Overcoming Therapeutic Inertia Maximizing Guideline Driven Medical Therapy in Heart Failure.ts
| Parenteral Antithrombotic Therapies for ACS and PCI.ts
| PCI in patients with CKD Insights from a nephrology and interventional cardiology partnership.ts
| Perlas practicas en manejo de lipidos.ts
| Perspectives on Pulmonary Hypertension.ts
| Pharmacologic and Lifestyle Management for ISHD Why Disparities in Care Matter.ts
| Pharmacology I Expanding the Cardiovascular Pharmacology Toolbox.ts
| Pharmacology II Tackling the Supersized Epidemic of Cardio-diabetes.ts
| Pharmacology III An Ounce of Prevention is Worth a Pound of Cure – Advances in Cardio-Oncology.ts
| Pharmacotherapy Considerations in Cardio-Obstetrics.ts
| Polite Parlays in Pulmonary Hypertension.ts
| Potential Mechanisms Responsible for the Effects of Incretins on Atherosclerosis.ts
| Practical Pearls on ASCVD and Lipid Management.ts
| Pre-operative Care for Non-Cardiac Surgery Emerging Strategies and Ongoing Controversies.ts
| Precision in Classification and Treatment of Heart Failure One Size Does Not Fit All.ts
| Precision PCI in the Real World What Do I Use Every Day.ts
| Proarrhythmia Look Outs! From the ICU to the Food We Eat.ts
| Professional Advancement Across the Academic Cardiology Life Course.ts
| Professionalism and Ethics in Cardiology.ts
| Progression of Pulmonary Arterial Hypertension Pharmacotherapy Plainly Played-out in a Patient Case.ts
| Protected PCI Diagnosis and Treatment of High-Risk and Complex Coronary Disease for Superior Long-term Outcomes.ts
| Pulmonary Hypertension Primer WHO Are the Groups.ts
| Raising the Clinical Suspicion for Hypertrophic Cardiomyopathy.ts
| Rapid Fire Session on Valvular Heart Disease.ts
| Re-imagining the 90-Day High-Risk Period Post-AMI Expert Discussions on Cholesterol Efflux and ApoA-I in Plaque Stabilization.ts
| Recent Trials in SIHD Translating Results into Clinical Practice.ts
| Registries in Cardiac Imaging How Will they Change Clinical Practice.ts
| Repair Is Not Correction Long Term Follow-up of Surgery for Congenital Heart Disease.ts
| Return To Play What The Experts Would Do.ts
| Reversible Cardiomyopathies Arrhythmias, Pacing, Dyssynchrony and Inflammation.ts
| Right Sided Valve Interventions.ts
| Role of Multimodality Imaging in Diagnosis and Management of Cardiovascular Complications in Patients with COVID-19.ts
| Sex Differences in Arrhythmias.ts
| Shock Teams and Shock Docs.ts
| So You Want To Be a Chief of Cardiology.ts
| Star Wars What Does the Future Hold for EP.ts
| Sticky Situations for Revascularization in SIHD When the Evidence Is Limited but Opinions Are Vast.ts
| Strategies for Bleeding Avoidance After Complex PCI.ts
| Streamlining diagnosis and treatment in chronic coronary artery disease.ts
| Stress Echo Beyond Obstructive CAD.ts
| Stroke Prophylaxis Treating the Untreated.ts
| Structural Complications & How to Deal with Them.ts
| Structural Heart Disease Challenges in 2021 – Aortic, Mitral and Tricuspid Diseases, Hypertrophic Cardiomyopathies.ts
| Tackling Cardiometabolic Risk A Case Based Discussion.ts
| The Advanced Heart Failure Therapies of LVAD and Transplant Who, What, When, Where, Why, and How DISCUSSION.ts
| The Advanced Heart Failure Therapies of LVAD and Transplant Who, What, When, Where, Why, and HowDIAPOSITIVAS.ts
| The Constant Debate TAVR Versus SAVR – One Size Does Not Fit All.ts
| The European Heart Journal’s Year in Cardiovascular Medicine.ts
| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 1.mp4
| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 2.mp4
| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 4.mp4
| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 5.mp4
| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand3.mp4
| The Future of Dyslipidemia Management.ts
| The TeleHealth Cardiac Team Challenges and Opportunities.ts
| The Time Has Come For Systematic Screening For Asymptomatic Atrial Fibrillation.ts
| The US-China Consensus on High Efficiency PVI Using RF Energy in Patients with Paroxysmal AF and AF Workflow Sharing.ts
| Thrombosis & Prevention in COVID-19 What Are We Missing.ts
| To Right a Wrong in Heart Failure.ts
| Top Indications for Cardiovascular Magnetic Resonance in Modern Cardiology.ts
| Topical Topics in Pulmonary Arterial Hypertension.ts
| Tough Choices Cases in Cardiogenic Shock.ts
| Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 1.mp4
| Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 2.mp4
| Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 3.mp4
| Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 4.mp4
| Transcatheter Mitral Valve Replacement Expanding Indications and Trial Update.ts
| Translational Cardiac Anatomy.ts
| Treat the Pump or Treat the Rhythm Let’s Talk About Both.ts
| Treating Comorbidities to Treat Heart Failure Sleep, Exercise, Weight Loss, Iron and More.ts
| Tricuspid Regurgitation No Longer The Forgotten Valve.ts
| Under the Bright Light Debates in Interventional Cardiology.ts
| Understanding the Impact of Lp(a) in ASCVD A focus on added CV risk, guidelines, and testing.ts
| Unfolding the Mysteries of Cardiac Amyloidosis.ts
| Uniquely Bicuspid Valve Two Leaflets and A Tool Kit.ts
| Universal Definition of Heart Failure.ts
| Updates in Management of Hypertrophic Cardiomyopathy.ts
| Use of Direct Oral Anticoagulants in Special Populations Complex Dosing Strategies and Complicated Patients.ts
| Valvular Conundrums Grey Area Cases, What the Experts Think.ts
| VASCEPA® (icosapent ethyl) Elevating the Standard of Care.ts
| Vascular Manifestations of COVID-19 Around the Globe.ts
| Vasculo-Oncology Lessons Learned for Clinical Practice in 2021.ts
| Venous Interventions 2021.ts
| Venous Thromboembolism Current Controversies and Practical Management.ts
| Virtual Outpatient Experience for Cardiac Electrophysiologists High Yield Topics.ts
| Vulnerable Plaques Intervention or Pharmacologic Therapy.ts
| Watchman Transmission.ts
| What Can We Learn From Each Other For Global Heart Failure Care.ts
| What You Don’t Know Can’t Help Them – Remote Management of Patients Using Wearables.ts
| What’s In a Name Practicalities of the 4th Universal Definition of MI.ts
| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 1.mp4
| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 2.mp4
| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 3.mp4
| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 4.mp4
| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 5.mp4
| When Fat Overpowers Muscle Obesity and the HFpEF Epidemic.ts
| Working Together to Improve Pediatric and Congenital Heart Disease Care Around the World 5.ts
| World Heart Federation Featured Research With Year in Review.ts
| Yes, No, Maybe How to Diagnose and Treat INOCA (Ischemia and No Obstructive Coronary Artery Disease) Today.ts
| Your PVI Toolkit.ts